| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.66B | 126.41B | 118.34B | 117.94B | 114.71B | 110.38B |
| Gross Profit | 27.31B | 25.70B | 18.88B | 23.82B | 27.86B | 27.16B |
| EBITDA | -29.69B | -28.17B | 1.69B | 7.78B | 9.73B | 10.83B |
| Net Income | -24.96B | -24.28B | -5.44B | 102.00M | 2.22B | 3.86B |
Balance Sheet | ||||||
| Total Assets | 169.40B | 149.43B | 186.33B | 190.00B | 191.40B | 190.40B |
| Cash, Cash Equivalents and Short-Term Investments | 35.16B | 13.50B | 11.21B | 10.55B | 18.98B | 23.37B |
| Total Debt | 92.14B | 93.53B | 93.93B | 93.82B | 94.34B | 97.17B |
| Total Liabilities | 131.81B | 133.19B | 148.09B | 146.09B | 148.33B | 149.21B |
| Stockholders Equity | 37.36B | 15.57B | 36.76B | 42.11B | 41.30B | 39.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.23B | 1.05B | -8.01B | -126.00M | 7.57B |
| Operating Cash Flow | 0.00 | 6.29B | 8.17B | 509.00M | 8.67B | 14.87B |
| Investing Cash Flow | 0.00 | -3.15B | -7.54B | -8.09B | -8.99B | -6.17B |
| Financing Cash Flow | 0.00 | -435.00M | -279.00M | -1.66B | -4.21B | -4.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥408.97B | 12.16 | 9.65% | 3.91% | 0.87% | 16.71% | |
74 Outperform | ¥180.92B | 17.43 | ― | 2.84% | 6.06% | 19.76% | |
74 Outperform | ¥333.84B | 12.62 | 5.47% | 3.41% | 2.60% | 9.50% | |
68 Neutral | ¥2.35T | 18.48 | 11.98% | 1.54% | 1.84% | -6.57% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥110.58B | 10.27 | ― | ― | 4.22% | -21.68% | |
60 Neutral | ¥164.10B | 17.88 | ― | 3.21% | -1.68% | 1262.84% |